MapLight Therapeutics, Inc. (MPLT)
NASDAQ: MPLT · Real-Time Price · USD
30.31
-0.33 (-1.08%)
At close: Apr 28, 2026, 4:00 PM EDT
29.00
-1.31 (-4.32%)
After-hours: Apr 28, 2026, 5:04 PM EDT
MapLight Therapeutics Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for MapLight Therapeutics stock have an average target of 32.67, with a low estimate of 28 and a high estimate of 37. The average target predicts an increase of 7.79% from the current stock price of 30.31.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for MapLight Therapeutics stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 3 | 5 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 5 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Initiates $37 | Strong Buy | Initiates | $37 | +22.07% | Apr 8, 2026 |
| TD Cowen | TD Cowen | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Apr 7, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Initiates $35 | Strong Buy | Initiates | $35 | +15.47% | Mar 19, 2026 |
| Stifel | Stifel | Strong Buy Initiates $28 | Strong Buy | Initiates | $28 | -7.62% | Nov 21, 2025 |
| Jefferies | Jefferies | Strong Buy Initiates $32 | Strong Buy | Initiates | $32 | +5.58% | Nov 21, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-4.02
from -18.56
EPS Next Year
-4.04
from -4.02
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | n/a | n/a | ||||||
| Avg | n/a | n/a | ||||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -3.62 | -2.68 | ||||||
| Avg | -4.02 | -4.04 | ||||||
| Low | -4.55 | -5.19 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.